AmBisome liposomale amfotericine B 50 mg clinical trials

Nebulised lIposomal aMphotericin B in chronic pUlmonary aSpergillosis: a deposition study

This study looks at how much of a medicine called AmBisome, given as a mist you breathe in, reaches the lungs. It aims to find the best dose for treating a fungal lung infection called chronic pulmonary aspergillosis, while also checking for any side effects.